CAPITAL INTERNATIONAL LTD /CA/
Position in CRSP — CRISPR Therapeutics AG
CIK 1065350
LOS ANGELES, CA
Position in CRSP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,057,839
+$390,780 QoQ
Shares Held
56,066
0.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#92
of 519 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $127,577,689 across 7 Biotechnology names. CRSP ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
97,334 | $48,348,717 | |
| 2 | RPRX |
Royalty Pharma plc
|
579,801 | $32,509,442 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
77,161 | $21,988,570 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,166 | $8,779,840 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,665 | $8,520,674 | |
| 6 | ASND |
Ascendis Pharma A/S
|
16,394 | $4,372,607 | |
| 7 | CRSP |
CRISPR Therapeutics AG
This page
|
56,066 | $3,057,839 |
All Filings in CRSP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,057,839 | 56,066 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,667,059 | 56,066 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,911,416 | 55,519 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,989,185 | 61,552 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,993,889 | 61,552 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,452,303 | 72,063 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,053,036 | 128,380 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,900,875 | 125,604 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,812,335 | 126,131 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,640,643 | 126,770 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,938,361 | 94,862 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,310,688 | 94,970 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,341,833 | 95,152 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,185,312 | 92,534 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,182,895 | 78,300 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,972,154 | 76,085 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,926,014 | 48,149 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,713,986 | 43,237 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $3,276,499 | 43,237 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,521,860 | 40,399 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,467,019 | 39,947 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,409,896 | 44,398 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $10,618,025 | 69,349 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,723,736 | 68,433 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||